This inventor holds 1 USPTO granted patent. Top assignee: University of Massachusetts. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations by Inventor Mengxi Wang
Introduction
Mengxi Wang is a notable inventor based in Worcester, MA (US). He has made significant contributions to the field of muscle biology through his innovative research and patented methods. His work focuses on the differentiation of myoblasts and the formation of myotubes, which are crucial for muscle development and regeneration.
Latest Patents
Mengxi Wang holds a patent titled "Compositions and methods for inducing myoblast differentiation and myotube formation." This patent describes methods for inducing the differentiation of mammalian myoblasts into myocytes by using oligonucleotides that decrease the expression of Mitogen-activated protein kinase kinase kinase kinase 4 (Map4k4) mRNA. Additionally, the patent outlines methods for promoting the formation of myotubes by contacting multiple myoblasts or myocytes with these oligonucleotides. The patent also includes methods for identifying candidate agents that can induce muscle formation, along with compositions that combine the oligonucleotides with other muscle therapeutic agents or muscle-building nutraceuticals. Mengxi Wang has 1 patent to his name.
Career Highlights
Mengxi Wang is affiliated with the University of Massachusetts, where he conducts his research. His work has implications for muscle health and therapeutic strategies for muscle-related diseases.
Collaborations
One of his notable collaborators is Michael P Czech, with whom he has worked on various research projects related to muscle biology.
Conclusion
Mengxi Wang's innovative approaches to muscle differentiation and regeneration highlight the importance of research in advancing therapeutic options for muscle health. His contributions are paving the way for future developments in this critical area of study.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
